NgeneBio Co., Ltd. (354200)

Overview

NGeneBio Co., Ltd., established in 2015 and based in Seoul, South Korea, focuses on the development of in vitro diagnostics, companion diagnostics products, and bioinformatics software. The company plays a vital role in the healthcare and biotechnology industry by offering advanced diagnostic solutions and genetic testing kits that cater to various medical conditions, including cancer, hematological malignancies, and genetic disorders. NGeneBio's commitment to innovation and precision in diagnostics is evident in its diverse product lineup designed to meet the needs of patients and healthcare providers worldwide.

Products and Services

NGeneBio Co., Ltd. offers a wide range of products and services that cater to different aspects of genetic testing and diagnostics:

• BRCAaccuTest and BRCAaccuTest PLUS: These reagent kits are designed for the detection of genetic variants associated with breast and ovarian cancer, as well as hereditary breast and ovarian cancer syndrome. They offer a reliable solution for individuals at risk of these cancers.
• HEMEaccuTest: A comprehensive clinical next-generation sequencing (NGS) kit that helps in diagnosing various hematological malignancies, including acute myeloid leukemia, acute lymphoid leukemia, myelodysplastic/myeloproliferative neoplasms, multiple myeloma, and lymphoma.
• SOLIDaccuTest: This product provides genetic variant screening for solid tumors, utilizing advanced techniques to identify and characterize mutations that can influence treatment strategies.
• HLAaccuTest: An in vitro diagnostic device for human leukocyte antigen typing, essential for determining compatibility in organ transplantation and understanding certain genetic predispositions to diseases.
• OncoaccuPanel: A next-generation sequencing test designed for solid tumor oncology, offering detailed insights into the genetic makeup of tumors to guide personalized treatment plans.
• NGeneAnalySys: An advanced bioinformatics software that simplifies the analysis of genetic testing data, providing clinicians and researchers with powerful tools to interpret complex genetic information efficiently.
• EasyHLAanalyzer: A software solution that facilitates HLA typing by identifying human leukocyte antigens from next-generation sequencing data, aiding in histocompatibility testing.
• IDaccuTest: This short tandem repeat (STR) test is used for a range of applications, including family relationship testing, identity verification, forensics, and chimerism analysis post-transplant.
• NGenePlex nCoV qRT-PCR Kit: A reagent kit for real-time reverse transcription-polymerase chain reaction assay, specifically designed for the qualitative detection of SARS-CoV-2 nucleic acids in patients suspected or confirmed to have COVID-19.